Download PDF
Semin Thromb Hemost
DOI: 10.1055/a-2621-0465
Original Article

Comparative Analysis of Four Risk Stratification Models to Identify Patients with Acute Pulmonary Embolism at Risk of Short-term Mortality

Kwadwo O. Bonsu 
1   School of Pharmacy, Memorial University, St. John's, NL, Canada
,
Stephanie W. Young
1   School of Pharmacy, Memorial University, St. John's, NL, Canada
2   Pharmacy Program, Newfoundland and Labrador Health Services, St. John's, NL, Canada
,
Tiffany Lee
1   School of Pharmacy, Memorial University, St. John's, NL, Canada
2   Pharmacy Program, Newfoundland and Labrador Health Services, St. John's, NL, Canada
,
Hai V. Nguyen
1   School of Pharmacy, Memorial University, St. John's, NL, Canada
,
Rufaro S. Chitsike
3   Division of Hematology, Newfoundland and Labrador Health Services, St. John's, NL, Canada
4   Faculty of Medicine (Hematology), Memorial University, St. John's, NL, Canada
› Author Affiliations
Funding The development, implementation, and evaluation of the Thrombosis Service, including this study, was supported by an unrestricted grant from Sanofi Canada and Bayer Canada.
› Further Information
   Permissions and Reprints

Abstract

Acute pulmonary embolism (PE) is potentially life-threatening, with up to 15% risk of death. We compared four risk stratification models to identify outpatients at risk of mortality up to 90 days post acute PE. A retrospective cohort study included outpatients aged ≥18 years with confirmed PE from June 1, 2014 to May 31, 2019, identified via diagnostic imaging reports. Simplified Pulmonary Embolism Severity Index (sPESI) and Hestia scores were calculated as per original derivation methods. Patients were stratified by four models: sPESI alone, Hestia alone, sPESI plus right ventricular dysfunction (RVD), and Hestia plus RVD. Model accuracy and discriminatory power for 30- and 90-day mortality were assessed by area under the receiver operating curve (AUC). The study comprised 785 outpatients (mean age 65.0 years; 42.2% male). Overall mortality rates were 4.1% at 30 days and 7.8% at 90 days. sPESI identified 31.5% as low risk versus 19.1% by Hestia. All models demonstrated 100% sensitivity and negative predictive value for 30-day mortality, but modest discriminatory power (AUC range: 59.2–67.1). sPESI consistently outperformed other models in both timeframes. Including RVD with sPESI or Hestia did not enhance accuracy and slightly reduced performance. The net reclassification index indicated minor improvement in non-event classification with RVD, but no benefit for identifying deaths. sPESI remains a modest yet effective predictor of mortality risk within 90 days following acute PE, consistently outperforming sPESI + RVD, Hestia alone, and Hestia + RVD at both 30 and 90 days. Adding RVD minimally improved predictive accuracy.

Keywords

pulmonary embolism - sPESI - Hestia criteria - right ventricular dysfunction - mortality

Previous Presentation

The abstract of this paper was presented at the American Society of Haematology Conference 2022 as a poster presentation with interim findings. The poster's abstract was published as conference proceedings in the Blood (2022) 140 (Supplement 1): 5686–5687. https://doi.org/10.1182/blood-2022-169358: Available at: https://ashpublications.org/blood/article/140/Supplement%201/5686/488031


Supplementary Material



Publication History

Received: 25 February 2025

Accepted: 25 May 2025

Accepted Manuscript online:
26 May 2025

Article published online:
17 June 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Martin SS, Aday AW, Allen NB. et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Committee. 2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation 2025; 151 (08) e41-e660
    Search in Google Scholar
  • 2 Kearon C, Akl EA, Ornelas J. et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016; 149 (02) 315-352
    Search in Google Scholar
  • 3 Becattini C, Agnelli G. Predictors of mortality from pulmonary embolism and their influence on clinical management. Thromb Haemost 2008; 100 (05) 747-751
    Search in Google Scholar
  • 4 Jiménez D, Yusen RD, Otero R. et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest 2007; 132 (01) 24-30
    Search in Google Scholar
  • 5 Aujesky D, Obrosky DS, Stone RA. et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172 (08) 1041-1046
    Search in Google Scholar
  • 6 Aujesky D, Perrier A, Roy P-M. et al. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med 2007; 261 (06) 597-604
    Search in Google Scholar
  • 7 Palas M, Silva BV, Jorge C, Almeida AG, Pinto FJ, Caldeira D. The accuracy of Hestia and simplified PESI to predict the prognosis in pulmonary embolism: systematic review with meta-analysis. TH Open 2022; 6 (04) e347-e353
    Search in Google Scholar
  • 8 Masotti L, Righini M, Vuilleumier N. et al. Prognostic stratification of acute pulmonary embolism: focus on clinical aspects, imaging, and biomarkers. Vasc Health Risk Manag 2009; 5 (04) 567-575
    Search in Google Scholar
  • 9 Zondag W, Mos IC, Creemers-Schild D. et al; Hestia Study Investigators. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 2011; 9 (08) 1500-1507
    Search in Google Scholar
  • 10 den Exter PL, Zondag W, Klok FA. et al; Vesta Study Investigators *. Efficacy and safety of outpatient treatment based on the Hestia clinical decision rule with or without N-terminal pro-brain natriuretic peptide testing in patients with acute pulmonary embolism. A randomized clinical trial. Am J Respir Crit Care Med 2016; 194 (08) 998-1006
    Search in Google Scholar
  • 11 Hendriks SV, Bavalia R, van Bemmel T. et al; YEARS investigators. Current practice patterns of outpatient management of acute pulmonary embolism: a post-hoc analysis of the YEARS study. Thromb Res 2020; 193: 60-65
    Search in Google Scholar
  • 12 Roy P-M, Penaloza A, Hugli O. et al; HOME-PE Study Group. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial. Eur Heart J 2021; 42 (33) 3146-3157
    Search in Google Scholar
  • 13 Bikdeli B, Lobo JL, Jiménez D. et al; RIETE Investigators. Early use of echocardiography in patients with acute pulmonary embolism: findings from the RIETE registry. J Am Heart Assoc 2018; 7 (17) e009042
    Search in Google Scholar
  • 14 Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med 2005; 165 (15) 1777-1781
    Search in Google Scholar
  • 15 Cho JH, Kutti Sridharan G, Kim SH. et al. Right ventricular dysfunction as an echocardiographic prognostic factor in hemodynamically stable patients with acute pulmonary embolism: a meta-analysis. BMC Cardiovasc Disord 2014; 14: 64
    Search in Google Scholar
  • 16 Darwish OS, Mahayni A, Patel M, Amin A. Cardiac troponins in low-risk pulmonary embolism patients: a systematic review and meta-analysis. J Hosp Med 2018; 13 (10) 706-712
    Search in Google Scholar
  • 17 Chen YL, Wright C, Pietropaoli AP. et al. Right ventricular dysfunction is superior and sufficient for risk stratification by a pulmonary embolism response team. J Thromb Thrombolysis 2020; 49 (01) 34-41
    Search in Google Scholar
  • 18 Konstantinides SV, Meyer G, Becattini C. et al; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41 (04) 543-603
    Search in Google Scholar
  • 19 Konstantinides SV, Torbicki A, Agnelli G. et al; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35 (43) 3033-3069 , 3069a–3069k
    Search in Google Scholar
  • 20 Nguyen ET, Hague C, Manos D. et al. Canadian Society of Thoracic Radiology/Canadian Association of Radiologists best practice guidance for investigation of acute pulmonary embolism, Part 1: acquisition and safety considerations. Can Assoc Radiol J 2022; 73 (01) 203-213
    Search in Google Scholar
  • 21 Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work?. Int J Methods Psychiatr Res 2011; 20 (01) 40-49
    Search in Google Scholar
  • 22 Giganti MJ, Shepherd BE. Multiple-imputation variance estimation in studies with missing or misclassified inclusion criteria. Am J Epidemiol 2020; 189 (12) 1628-1632
    Search in Google Scholar
  • 23 DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44 (03) 837-845
    Search in Google Scholar
  • 24 de Hond AAH, Steyerberg EW, van Calster B. Interpreting area under the receiver operating characteristic curve. Lancet Digit Health 2022; 4 (12) e853-e855
    Search in Google Scholar
  • 25 Quezada CA, Bikdeli B, Villén T. et al. Accuracy and interobserver reliability of the simplified Pulmonary Embolism Severity Index versus the Hestia criteria for patients with pulmonary embolism. Acad Emerg Med 2019; 26 (04) 394-401
    Search in Google Scholar
  • 26 Beam DM, Kahler ZP, Kline JA. Immediate discharge and home treatment with rivaroxaban of low-risk venous thromboembolism diagnosed in two U.S. emergency departments: a one-year preplanned analysis. Acad Emerg Med 2015; 22 (07) 788-795
    Search in Google Scholar
  • 27 Wells P, Peacock WF, Fermann GJ. et al. The value of sPESI for risk stratification in patients with pulmonary embolism. J Thromb Thrombolysis 2019; 48 (01) 149-157
    Search in Google Scholar
  • 28 Elias A, Mallett S, Daoud-Elias M, Poggi J-N, Clarke M. Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis. BMJ Open 2016; 6 (04) e010324
    Search in Google Scholar